In today’s session Monsanto Company (MON) registered an unusually high (205) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the April, 2017 call, expecting serious MON increase. With 205 contracts traded and 2604 open interest for the Apr, 17 contract, it seems this is a quite bullish bet. The option with symbol: MON170421C00100000 closed last at: $5.15 or 3% up. About 622,498 shares traded hands. Monsanto Company (NYSE:MON) has risen 13.71% since April 5, 2016 and is uptrending. It has outperformed by 11.76% the S&P500.
Monsanto Company (NYSE:MON) Ratings Coverage
Out of 20 analysts covering Monsanto Company (NYSE:MON), 14 rate it a “Buy”, 1 “Sell”, while 5 “Hold”. This means 70% are positive. Monsanto Company has been the topic of 39 analyst reports since August 25, 2015 according to StockzIntelligence Inc. The firm has “Buy” rating given on Thursday, October 8 by Deutsche Bank. Canaccord Genuity maintained it with “Buy” rating and $126 target price in Thursday, August 27 report. The stock of Monsanto Company (NYSE:MON) has “Buy” rating given on Friday, October 9 by Argus Research. The stock has “Neutral” rating given by JP Morgan on Thursday, October 8. The stock has “Buy” rating given by Deutsche Bank on Thursday, September 15. The firm has “Buy” rating given on Friday, October 9 by Stifel Nicolaus. As per Tuesday, December 1, the company rating was upgraded by Atlantic Securities. The firm has “Buy” rating by UBS given on Thursday, October 8. The stock of Monsanto Company (NYSE:MON) has “Neutral” rating given on Tuesday, September 27 by Goldman Sachs. Barclays Capital maintained the stock with “Equal Weight” rating in Thursday, January 7 report.
According to Zacks Investment Research, “Monsanto is a leading global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. The combination of its herbicides, seeds and related genetic trait products provides growers with integrated solutions to more efficiently and cost effectively produce crops at higher yields, while controlling weeds, insects and diseases. Its base business, led by Roundup and coupled with the latest tools in biotechnology, genomics and molecular breeding.”
Insitutional Activity: The institutional sentiment increased to 0.91 in 2016 Q2. Its up 0.10, from 0.81 in 2016Q1. The ratio improved, as 88 funds sold all Monsanto Company shares owned while 334 reduced positions. 142 funds bought stakes while 243 increased positions. They now own 338.57 million shares or 4.89% less from 355.97 million shares in 2016Q1.
Panagora Asset Management Inc owns 25,185 shares or 0.01% of their US portfolio. Kornitzer Capital Mgmt Ks last reported 0.08% of its portfolio in the stock. Geneva Advisors Ltd Llc holds 403,180 shares or 0.82% of its portfolio. Lagoda Mgmt Ltd Partnership last reported 76,198 shares in the company. Bridges Investment Counsel holds 0.2% or 10,890 shares in its portfolio. Moreover, Telos Capital Mgmt Inc has 0.12% invested in Monsanto Company (NYSE:MON) for 2,424 shares. Beacon Gru accumulated 13,839 shares or 0.31% of the stock. State Of New Jersey Common Pension Fund D holds 0.14% or 300,000 shares in its portfolio. Crystal Rock Capital Mngmt has invested 2.26% of its portfolio in Monsanto Company (NYSE:MON). Da Davidson owns 10,376 shares or 0.03% of their US portfolio. The Illinois-based High Pointe Capital Management Ltd Liability Company has invested 1.07% in Monsanto Company (NYSE:MON). First City Cap reported 4,239 shares or 0.33% of all its holdings. Pacad has invested 0.27% of its portfolio in Monsanto Company (NYSE:MON). Adirondack accumulated 0.01% or 160 shares. Moreover, Cadence has 0.03% invested in Monsanto Company (NYSE:MON) for 3,468 shares.
Insider Transactions: Since October 10, 2016, the stock had 1 insider purchase, and 2 sales for $7.90 million net activity. $361,319 worth of Monsanto Company (NYSE:MON) was bought by MCMILLAN CHARLES S on Monday, October 10. Another trade for 310 shares valued at $31,958 was made by MIZELL STEVEN on Monday, October 10. FRALEY ROBERT T also sold $8.23M worth of Monsanto Company (NYSE:MON) on Thursday, October 13.
Monsanto Company , along with its subsidiaries, is a well-known provider of agricultural products for farmers. The company has a market cap of $43.59 billion. The Firm provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. It has a 32.9 P/E ratio. The Firm operates through two divisions: Seeds and Genomics, and Agricultural Productivity.
MON Company Profile
Monsanto Company (Monsanto), incorporated on February 9, 2000, along with its subsidiaries, is a well-known provider of agricultural products for farmers. The Firm provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Firm operates through two divisions: Seeds and Genomics, and Agricultural Productivity.
More notable recent Monsanto Company (NYSE:MON) news were published by: Stltoday.com which released: “States to join federal probes of Dow-DuPont, Bayer-Monsanto mergers” on November 08, 2016, also Businesswire.com with their article: “Monsanto Company Board Sets Record and Meeting Dates for Next Annual Meeting …” published on November 01, 2016, Bloomberg.com published: “Monsanto Talked to Three Other Companies Before Bayer Deal” on October 19, 2016. More interesting news about Monsanto Company (NYSE:MON) were released by: Businesswire.com and their article: “Fitch Rates Monsanto Company’s Term Loan ‘A-‘; On Negative Watch” published on November 03, 2016 as well as Wsj.com‘s news article titled: “Bayer CEO Defends Planned Acquisition of Monsanto” with publication date: October 26, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.